Rxsight

Rxsight Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Rxsight (RXST) as of Nov 22, 2026 is 368.08. In the previous year, Cash Conversion Cycle (CCC) was 233.93 — a change of 57.35% (higher).

Cash Conversion Cycle

368.08

YoY

57.35%

Last updated:

Cash Conversion Cycle (CCC) of Rxsight is 2025 368.08 . Cash Conversion Cycle (CCC) of Rxsight was 2024 233.93 . It decreases by 57.35% higher compared to the previous year.

The Rxsight Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2019
581.60 USD
Jan 1, 2020
273.40 USD
Jan 1, 2021
207.24 USD
Jan 1, 2022
243.35 USD
Jan 1, 2023
223.24 USD
Jan 1, 2024
233.93 USD
Jan 1, 2025
368.08 USD
The Rxsight Cash Conversion Cycle history
YEARCash Conversion CycleYoY
368.08+57.35%
233.93+4.79%
223.24-8.26%
243.35+17.42%
207.24-24.20%
273.40-52.99%
581.60—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rxsight Stock analysis

What does Rxsight do? Rxsight Inc is an innovative company that specializes in developing innovative solutions for eye treatments. The company aims to make a positive contribution to the quality of life for patients suffering from eye problems. Rxsight Inc was founded in 2008 by Jim Taylor, who had previously worked in computer graphics at Pixar Animation Studios and was now involved in new technologies for ophthalmology. The business model of Rxsight Inc is based on the development and marketing of medical products that improve the treatment of eye diseases. The company focuses on the field of dynamic ophthalmology, which aims to improve treatment options for eye diseases by focusing on the influence of eye movements and changes in pupil size. Rxsight Inc is divided into various divisions, with an important division focusing on research and development of products that can improve the treatment of eye diseases. The company invests heavily in developing innovative products. Additionally, Rxsight Inc is also involved in the manufacturing and marketing of medical products. Rxsight Inc's products include special contact lenses that can be individually customized through precise measurement of the eye lens. These contact lenses can help patients achieve better visual quality after eye surgery. Rxsight Inc also offers certain measuring devices that are used for measuring and analyzing eye movements and pupil size. Another important product from Rxsight Inc is the "Light Adjustable Lens System," which is a system for intraocular lenses that operates based on feedback from light and energy. The system allows for an individualized process for adjusting the strength of intraocular lenses. With the "Light Adjustable Lens System," patients can achieve significantly improved visual quality after cataract surgery. Overall, Rxsight Inc has established itself as an innovative company in ophthalmology. The company focuses on research and development to provide new technologies for the treatment of eye diseases. Rxsight Inc emphasizes dynamic ophthalmology to consider the influence of eye movements and pupil size in the therapy of eye diseases. With its products, Rxsight Inc makes an important contribution to improving the visual quality of patients. Rxsight is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rxsight stock

Cash Conversion Cycle (CCC) of Rxsight is 368.08 in 2025.

Cash Conversion Cycle (CCC) of Rxsight changed from 233.93 to 368.08, representing a 57.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Rxsight since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Rxsight with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Rxsight

All Key Metrics — Rxsight